This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo
C3_RESPIRATORY_INTRATHORACIC3_NAS_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
109 |
4. Check minimum number of eventsNone |
109 |
5. Include endpointsNone |
109 |
6. Filter based on genotype QC (FinnGen only) |
105 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 105 | 31 | 74 |
| Unadjusted period prevalence (%) | 0.03 | 0.01 | 0.03 |
| Median age at first event (years) | 69.71 | 64.39 | 71.94 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 109
- Matched controls
- 1090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
+∞
61.4
53
*
130
Kela drug reimbursment
Malignant tumour
+∞
42.5
38
*
C39.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
+∞
33.0
30
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
12.5
31.2
37
43
H02AB02
ATC
dexamethasone; systemic
204.3
30.4
30
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
20.4
19
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.5
20.4
37
70
C39.0
ICD-10 Finland
Malignant neoplasm: Upper respiratory tract, part unspecified
+∞
18.2
17
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
17.1
16
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
30.1
16.8
22
9
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.9
16.8
31
59
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
16.0
15
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
34.5
15.8
20
7
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
14.9
14
*
N02AA05
ATC
oxycodone; systemic
5.5
14.7
36
89
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
13.8
13
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
13.8
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
13.8
13
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
13.8
13
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
12.7
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.7
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.7
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.7
11
*
A04AA01
ATC
ondansetron; systemic, rectal
28.6
11.5
15
6
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
14.1
11.4
19
16
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
10.6
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
10.6
10
*
8000/3-C39.9
ICD-O-3
Neoplasm, malignant of ill-defined sites within respiratory system
+∞
9.5
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.5
9
*
JN4BD
NOMESCO Finland
Extensive body CT
9.1
8.8
18
23
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
8.4
8
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
8.4
8
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
8.4
8
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
11.4
8.3
15
15
Z51.5
ICD-10 Finland
Palliative care
8.7
7.7
16
21
XX3DW
NOMESCO Finland
Time consuming IT work
10.5
7.5
14
15
WF002
NOMESCO Finland
Radical radiotherapy
85.7
7.5
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.4
7
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.4
7
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
7.4
7
*
ZX120
NOMESCO Finland
Intravenous
4.9
7.0
17
40
WF049
NOMESCO Finland
Radiotherapy of metastasis
74.0
6.5
7
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
19.4
6.4
9
5
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.3
6
*
GDC00
NOMESCO Finland
Lobectomy of lung
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
37
657
0.34
6.72
3.7
5.2
2.47
2.53
mmol/l
0.15
32
588
9
5
19.41
6.38
1.6
1.6
35.68
10.43
ug/l
—
9
5
40
650
0.39
5.20
4.7
5.0
5.74
6.13
mmol/l
1.94
34
564
8
9
9.48
4.36
1.0
1.0
—
—
—
0
0
8
12
7.09
3.74
2.5
1.2
75.88
93.96
u/ml
—
8
12
33
539
0.44
3.70
30.5
17.0
14.34
15.46
%
2.29
33
523
30
502
0.44
3.52
3.3
3.8
15.36
14.92
pmol/l
0.47
30
432
16
335
0.39
3.17
1.9
2.1
87.29
90.56
pmol/l
—
7
181
10
26
4.13
3.07
1.9
3.8
—
—
—
0
0
5
5
10.39
3.01
1.2
1.0
9.40
9.00
u/l
—
5
5
5
6
8.65
2.77
1.2
1.2
297.20
230.00
u/l
—
5
6
22
382
0.47
2.60
4.0
3.1
50.73
50.08
u/l
0.02
22
345
5
7
7.41
2.57
1.4
1.1
156.24
60.77
pmol/l
—
5
7
17
321
0.44
2.50
3.1
2.5
—
—
—
0
0
17
316
0.45
2.38
7.6
4.3
2.78
2.46
ug/l
0.17
17
270
7
19
3.86
2.19
1.1
1.4
—
—
—
0
0
10
39
2.72
2.00
14.3
7.6
0.49
0.80
%
—
10
39
10
39
2.72
2.00
14.1
7.7
0.87
1.47
%
—
10
39
18
99
1.98
1.70
2.9
1.9
0.81
0.83
mmol/l
0.36
18
91
15
261
0.51
1.66
5.9
4.0
—
—
—
0
0
15
79
2.04
1.58
13.8
5.7
102.27
103.62
mmol/l
0.29
15
79
8
160
0.46
1.38
5.0
2.5
0.94
0.85
ug/l
—
8
111
23
337
0.60
1.37
4.2
4.1
49.47
55.93
ng/l
0.15
15
255
12
200
0.55
1.13
1.6
1.6
21.81
18.80
nmol/l
0.48
12
167
7
32
2.27
1.10
2.3
1.9
8.63
14.43
nmol/l
—
7
27
0
28
0.00
0.99
0.0
1.5
—
—
—
0
0
0
28
0.00
0.99
0.0
1.4
—
34.82
—
0
22
0
30
0.00
0.99
0.0
1.0
—
—
—
0
0
0
20
0.00
0.61
0.0
1.3
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
10
67
1.54
0.51
14.1
6.8
115.50
123.88
g/l
—
10
67
19
240
0.75
0.49
4.4
2.9
—
—
—
0
0
7
49
1.46
0.47
1.6
1.4
—
—
—
0
0
5
33
1.54
0.42
23.8
7.5
27.40
24.02
mmol/l
—
5
33
7
102
0.66
0.42
11.1
8.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
9
68
1.35
0.39
1.9
2.3
25.22
7.95
umol/l
—
9
57
25
295
0.80
0.38
3.4
2.2
—
—
—
0
0
5
76
0.64
0.37
1.2
1.2
—
—
—
0
0
12
154
0.75
0.35
4.1
3.4
193.33
189.30
ng/l
0.01
12
124
18
149
1.25
0.30
3.2
1.8
—
—
—
0
0
10
77
1.33
0.27
2.0
1.7
—
—
—
0
0
10
79
1.29
0.23
2.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
6
49
1.24
0.20
2.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
76
0.78
0.16
2.8
3.5
—
—
—
0
0
34
316
1.11
0.15
11.6
4.8
1.20
1.21
mmol/l
0.23
34
274
20
221
0.88
0.14
2.5
2.1
65.45
80.20
u/l
0.29
20
201
17
189
0.88
0.13
3.6
2.7
27.06
30.47
u/l
0.81
17
175
5
61
0.81
0.08
1.6
2.0
37.80
33.98
u/l
—
5
46
10
110
0.90
0.05
2.2
1.7
28.31
30.01
s
—
10
105
35
361
0.96
0.04
14.7
17.5
1.47
1.44
inr
0.05
11
103
12
118
1.02
0.00
1.9
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
28.67
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
14.60
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
17.54
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
6
65
0.92
-0.00
6.2
3.8
2.13
1.71
mmol/l
—
6
52
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
19.36
—
0
5
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_RESPIRATORY_INTRATHORACIC3_NAS_WIDE – Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).